Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Health In Tech Q2 EPS $0.01, Inline, Sales $9.314M Beat $7.425M Estimate

Author: Benzinga Newsdesk | July 21, 2025 04:32pm
Health In Tech (NASDAQ:HIT) reported quarterly earnings of $0.01 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $9.314 million which beat the analyst consensus estimate of $7.425 million by 25.45 percent. This is a 86.21 percent increase over sales of $5.002 million the same period last year.

Posted In: HIT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist